TANG CAPITAL PARTNERS LP 13D/13G Filings for Quince Therapeutics, Inc. (QNCX)

TANG CAPITAL PARTNERS LP 13D and 13G filings for Quince Therapeutics, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2024-02-14
4:00 pm
Sale
2023-12-3113GQUINCE THERAPEUTICS, INC
QNCX
TANG CAPITAL PARTNERS LP16,100
7.500%
-2,000decrease
(-11.05%)
Filing
2023-03-31
4:00 pm
Purchase
2023-03-2113GQUINCE THERAPEUTICS, INC
QNCX
TANG CAPITAL PARTNERS LP18,100
9.980%
18,100increase
(New Position)
Filing